We found that the promoter regions of TFF1 and MAGEA1 were hypomethylated in cancer compared with adjacent samples (p < 10-5) and in cancer vs. control mammoplasty samples (p < 10-4; Tables 3 and 4). Here, MAGEA1 is linked to cancer.